The UK site where Pfizer has performed inhalation R&D is now on the market as “Discovery Park.” The company announced the closing of the site, which employed 2400 people, in February 2011. Although a representative said, “The name Discovery Park reflects our hope that the site will continue, in part at least, to be a centre for research and development,” the sales brochure apparently also describes possibilities for retail, housing, or leisure.
Read the BBC report.
Read the Reuters article.
published on
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
